Compounds for the treatment of kidney disease.
CL202601325A1Pending Publication Date: 2026-07-10VERTEX PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202601325
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-29
- Filing Date
- 2026-04-24
- Publication Date
- 2026-07-10
Abstract
The description provides polycystin-1 (PC1) correctors, pharmaceutical compositions containing at least one such corrector, methods for treating autosomal dominant polycystic kidney disease using such correctors and pharmaceutical compositions, and processes for manufacturing such correctors.
Need to check novelty before this filing date? Find Prior Art